In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Capricor Therapeutics Inc (NASDAQ: CAPR) was $13.89 for the day, up 3.81% from the previous closing price of $13.38. In other words, the price has increased by $3.81 from its previous closing price. On the day, 1.32 million shares were traded.
Ratios:
Our analysis of CAPR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.55 and its Current Ratio is at 6.55. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Roth Capital on May 20, 2025, initiated with a Buy rating and assigned the stock a target price of $31.
On May 17, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on May 17, 2024, with a $14 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Stock Price History:
Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is 32.91%, while the 200-Day Moving Average is calculated to be 5.88%.
Shares Statistics:
A total of 45.68M shares are outstanding, with a floating share count of 40.15M. Insiders hold about 12.16% of the company’s shares, while institutions hold 40.49% stake in the company.
